Neuropace Inc
Ownership
Ownership Structure
Who owns Neuropace Inc (NPCE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 74.5% of the shares are freely tradable; institutional investors hold 96.3%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Polar Capital Holdings PLC | 9.61 | 3,298,104 | +0.0 | 06/30/2026 |
| Soleus Capital Management, L.P. | 8.48 | 2,911,122 | -0.7 | 06/30/2026 |
| First Light Asset Management, LLC | 8.34 | 2,861,167 | +16.3 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 7.73 | 2,654,391 | +3.4 | 06/30/2026 |
| BlackRock Inc | 7.22 | 2,477,603 | +5.6 | 06/30/2026 |
| Orbimed Advisors LLC | 4.39 | 1,505,125 | -28.2 | 06/30/2026 |
| Driehaus Capital Management LLC | 4.22 | 1,447,391 | -0.3 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.57 | 1,227,072 | +9.2 | 06/30/2026 |
| Deutsche Bank AG | 2.74 | 938,919 | +0.7 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Polar Capital Healthcare Opports Inc | 8.41 | 2,888,289 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Becker Joel | CHIEF EXECUTIVE OFFICER | 138,000 | 1,697,400 $ | Sep 3, 2026 | direct |
| Williams Patrick F. | Chief Financial Officer | 67,508 | 830,348 $ | Sep 20, 2026 | direct |
| Morrell Martha | CHIEF MEDICAL OFFICER | 51,357 | 631,691 $ | Sep 24, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Morrell Martha | CHIEF MEDICAL OFFICER | Other | 335 | 13.97 | 4,680 |
| Sep 20, 2026 | Williams Patrick F. | Chief Financial Officer | Other | 1,162 | 14.28 | 16,593 |
| Sep 3, 2026 | Becker Joel | CHIEF EXECUTIVE OFFICER | Other | 1,310 | 14.75 | 19,323 |
| Aug 27, 2026 | Morrell Martha | CHIEF MEDICAL OFFICER | Other | 358 | 14.13 | 5,059 |
| Aug 27, 2026 | Becker Joel | CHIEF EXECUTIVE OFFICER | Other | 1,126 | 14.13 | 15,910 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.